Understanding AL Amyloidosis
The inaugural meeting of the Amyloidosis Forum took place in November 2019, in the Great Room at the FDA. This meeting established the priorities for the Forum. To learn more about the priorities read The Amyloidosis Forum: A public private partnership to advance drug development in AL amyloidosis.
The following publications resulted from the meeting:
Lousada and The Inaugural Amyloidosis Forum Panelists, Orphanet Journal of Rare Diseases (2020) 15:268
Isabelle Lousada, Vaishali Sanchorawala, Angela Dispenzieri, Kristen Hsu, Robyn Himick, Preston Dunnmon, Mathew Maurer, International Society of Amyloidosis, Annual Meeting 2020